KRAS and MAPK1 Gene Amplification in Type II Ovarian Carcinomas

ダウンロード数 : ? 件

この文献の参照には次のURLをご利用ください : https://ir.lib.shimane-u.ac.jp/53774

言語	英語
著者	Rahman Mohammed Tanjimur Departments of Obstetrics and Gynecology, Shimane University School of Medicine, Enyacho 89-1, Izumo, Shimane 6938501, Japan 中山健太郎 Rahman Munmun Departments of Obstetrics and Gynecology, Shimane University School of Medicine, Enyacho 89-1, Izumo, Shimane 6938501, Japan Katagiri Hiroshi Departments of Obstetrics and Gynecology, Shimane University School of Medicine, Enyacho 89-1, Izumo, Shimane 6938501, Japan Katagiri Atsuko Departments of Obstetrics and Gynecology, Shimane University School of Medicine, Enyacho 89-1, Izumo, Shimane 6938501, Japan 石橋朋佳石川雅子佐藤恵美飯田幸司 Nakayama Naomi Department of Biocehmistory, Shimane University School of Medicine, Izumo, Shimane 6938501, Japan Ishikawa Noriyuki Department of Organ Pathology, Shimane University School of Medicine, Izumo, Shimane 6938501, Japan Miyazaki Kohji Departments of Obstetrics and Gynecology, Shimane University School of Medicine, Enyacho 89-1, Izumo, Shimane 6938501, Japan
主題	type II ovarian carcinoma; KRAS; MAPK1; gene amplification; survival; MEK inhibitor
掲載誌名	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
巻	14
号	7
開始ページ	13748
終了ページ	13762
ISSN	1422-0067
発行日	2013-07
DOI	10.3390/ijms140713748
PubMed ID	23820584
出版者	MDPI AG
資料タイプ	学術雑誌論文
部局	医学部
備考	This study was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology in Japan.